Clinical trials also showed that anti‐PD‐L1 antibodies combined with radiotherapy promoted the penetration of CD8+ T cells and enhanced the antitumor effect on NSCLC synergistically.86 This evidence concerns the gene CD274 and non-small cell lung carcinoma.